ES500869A0 - Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin - Google Patents

Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin

Info

Publication number
ES500869A0
ES500869A0 ES500869A ES500869A ES500869A0 ES 500869 A0 ES500869 A0 ES 500869A0 ES 500869 A ES500869 A ES 500869A ES 500869 A ES500869 A ES 500869A ES 500869 A0 ES500869 A0 ES 500869A0
Authority
ES
Spain
Prior art keywords
trada
concen
cisplatin
procedure
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500869A
Other languages
English (en)
Spanish (es)
Other versions
ES8206545A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES8206545A1 publication Critical patent/ES8206545A1/es
Publication of ES500869A0 publication Critical patent/ES500869A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES500869A 1980-03-31 1981-03-30 Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin Granted ES500869A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
ES8206545A1 ES8206545A1 (es) 1982-08-16
ES500869A0 true ES500869A0 (es) 1982-08-16

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500869A Granted ES500869A0 (es) 1980-03-31 1981-03-30 Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin

Country Status (30)

Country Link
JP (1) JPS56152415A (xx)
KR (1) KR860000841B1 (xx)
AR (1) AR225500A1 (xx)
AT (1) AT370996B (xx)
AU (1) AU541056B2 (xx)
BE (1) BE888209A (xx)
CA (1) CA1162479A (xx)
CH (1) CH647481A5 (xx)
CS (1) CS246051B2 (xx)
DD (1) DD157762A5 (xx)
DE (1) DE3112272A1 (xx)
DK (1) DK158564C (xx)
ES (1) ES500869A0 (xx)
FI (1) FI70670C (xx)
FR (1) FR2480605A1 (xx)
GB (1) GB2074028B (xx)
GR (1) GR72769B (xx)
HU (1) HU183379B (xx)
IE (1) IE51070B1 (xx)
IL (1) IL62517A (xx)
IT (1) IT1170838B (xx)
LU (1) LU83270A1 (xx)
NL (1) NL8101531A (xx)
NO (1) NO156675C (xx)
NZ (1) NZ196519A (xx)
PH (1) PH17152A (xx)
PT (1) PT72774B (xx)
SE (1) SE455045B (xx)
SU (1) SU1056893A3 (xx)
ZA (1) ZA812084B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
IT8148090A0 (it) 1981-03-24
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
JPS56152415A (en) 1981-11-26
NL8101531A (nl) 1981-10-16
ES8206545A1 (es) 1982-08-16
ATA150481A (de) 1982-10-15
NO811081L (no) 1981-10-01
JPS6360008B2 (xx) 1988-11-22
IL62517A (en) 1984-01-31
IE810715L (en) 1981-09-30
FI70670B (fi) 1986-06-26
FR2480605A1 (fr) 1981-10-23
CA1162479A (en) 1984-02-21
HU183379B (en) 1984-04-28
AU6816681A (en) 1981-10-08
PT72774A (en) 1981-04-01
DK144281A (da) 1981-10-01
NO156675C (no) 1987-11-04
DE3112272C2 (xx) 1990-09-27
FR2480605B1 (xx) 1984-05-11
KR860000841B1 (ko) 1986-07-09
CS246051B2 (en) 1986-10-16
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
NZ196519A (en) 1983-06-17
KR830004849A (ko) 1983-07-20
BE888209A (fr) 1981-09-30
DE3112272A1 (de) 1982-04-29
PT72774B (en) 1982-11-16
DD157762A5 (de) 1982-12-08
SU1056893A3 (ru) 1983-11-23
AT370996B (de) 1983-05-25
GB2074028A (en) 1981-10-28
FI70670C (fi) 1986-10-06
NO156675B (no) 1987-07-27
IE51070B1 (en) 1986-09-17
AR225500A1 (es) 1982-03-31
DK158564C (da) 1990-11-05
AU541056B2 (en) 1984-12-13
GR72769B (xx) 1983-12-02
IL62517A0 (en) 1981-05-20
LU83270A1 (fr) 1981-10-29
IT1170838B (it) 1987-06-03
SE8101990L (sv) 1981-11-13
PH17152A (en) 1984-06-13
DK158564B (da) 1990-06-11

Similar Documents

Publication Publication Date Title
ES504905A0 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
ES499079A0 (es) Un procedimiento para la preparacion de un compuesto
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES499077A0 (es) Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES506141A0 (es) Un procedimiento para la preparacion de piridin- y pira- cin-derivados
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES506992A0 (es) Un procedimiento para la preparacion de una macroliada.
ES503188A0 (es) Un procedimiento para la preparacion de una 1-benzoil-urea 3-sustituida
ES499609A0 (es) Un procedimiento para la preparacion de una 3-yodometil-ce- falosporina
ES507506A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES505090A0 (es) Procedimiento para la preparacion de una coordinacion de compuesto de platero.
ES506216A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES504323A0 (es) Un procedimiento para la preparacion de un compuesto
ES504741A0 (es) Un procedimiento para la preparacion de una composicion esporicida de dialdehido-diol.
ES500897A0 (es) Un procedimiento para la preparacion de una mezcla de hidro-carburos
ES503682A0 (es) Un procedimiento para la preparacion de una isoxazolilimida-zolidinona
ES500869A0 (es) Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin
ES502153A0 (es) Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos.
ES492230A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
ES505019A0 (es) Un procedimiento para la preparacion de compuestos
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505